ERBB2 and breast neoplasm: In the results, scientists observed that oligoclonal antibody conjugated DOX-loaded liposomes showed an increased binding efficiency to HER2 overexpressing BT-474 and SK-BR-3 breast tumor cells and HER2-negative human breast epithelial MCF-10A cell lines.